Resveratrol protects against Schistosoma mansoni-induced liver fibrosis by targeting the Sirt-1/NF-&#954;B axis.

Mostafa, Dalia Kamal; Eissa, Maha M; Ghareeb, Doaa A; Abdulmalek, Shaymaa; Hewedy, Wafaa A

Resveratrol protects against Schistosoma mansoni-induced liver fibrosis by targeting the Sirt-1/NF-κB axis.

Mostafa, Dalia Kamal; Eissa, Maha M; Ghareeb, Doaa A; Abdulmalek, Shaymaa; Hewedy, Wafaa A.

Afiliação

Mostafa DK; Clinical Pharmacology Department, Faculty of Medicine, Alexandria University, Al-Moassat Medical Campus, Elhadara, Alexandria, 21561, Egypt.
Eissa MM; Medical Parasitology Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
Ghareeb DA; Biochemistry Department, Faculty of Science, Alexandria University, Alexandria, Egypt.
Abdulmalek S; Biochemistry Department, Faculty of Science, Alexandria University, Alexandria, Egypt.
Hewedy WA; Clinical Pharmacology Department, Faculty of Medicine, Alexandria University, Al-Moassat Medical Campus, Elhadara, Alexandria, 21561, Egypt. wafaa.hewedy@alexmed.edu.eg.

Inflammopharmacology ; 32(1): 763-775, 2024 Feb.

Article em En | MEDLINE | ID: mdl-38041753

Assuntos

Schistosoma mansoni; Esquistossomose; Camundongos; Animais; Masculino; Humanos; Schistosoma mansoni/metabolismo; NF-kappa B/metabolismo; Resveratrol/farmacologia; Sirtuína 1; Cirrose Hepática/tratamento farmacológico

Palavras-chave

Liver fibrosis; NF-κB; Portal pressure; Resveratrol; Schistosomiasis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Schistosoma mansoni / Esquistossomose Limite: Animals / Humans / Male Idioma: En Revista: Inflammopharmacology Assunto da revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Egito

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google